Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer
Authors:
- 1 January 2010
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 46 (1) , 102-109
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer, 2009
- Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2008
- Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinomaCancer, 2005
- Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective studyGynecologic Oncology, 2003
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1999
- Radical cytoreductive surgery combined with platinums-carboplatin and cisplatin chemotherapy for advanced ovarian cancerInternational Journal of Gynecological Cancer, 1999
- The impact of subspecialty training on the management of advanced ovarian cancerGynecologic Oncology, 1992
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinomaGynecologic Oncology, 1985